Tag
Former OpenAI executive Fidji Simo discusses her new startup ChronicleBio, which aims to use AI and a biobank of 3,500 blood samples to find cures for chronic conditions like POTS.
GSK expands its $110M AI drug discovery partnership with Relation Therapeutics, emphasizing that clean, disease-specific biological data from lab experiments is more valuable than larger models. The move highlights an industry-wide pivot toward proprietary data as a competitive moat in AI-driven pharma.
SANE is a novel schema-aware evaluation paradigm for natural-language (text-to-SQL) querying of biological/pharmacological datasets, enabling automatic benchmark generation tied to real experimental schemas. The study shows that few-shot LLMs with structured prompting can achieve accurate SQL generation without fine-tuning, with most failures stemming from ambiguous inputs rather than incorrect query generation.